← Back to all grants

Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)

National Institutes of Health

funding_unverified
Status Published
Posted Date Dec 5, 2023
Close Date Mar 13, 2026 (Fixed)
Rural Tier Rural Eligible
Scope Nationwide
Summary

This Notice of Funding Opportunity (NOFO) invites applications to usethe NIH INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) to access resources to generate a large volume of integrated genomic and multi-omics data to facilitate discovery of the molecular mechanisms of health conditions related to Down syndrome. These data, and associated clinical and phenotypic data, will become part of the INCLUDE Project data resource for sharing with the research community. No funding will be provided directly to applicants under this NOFO. Applicants are encouraged to propose omics essays of existing biospecimens collected from individuals with Down syndrome and controls. The program will accept applications that propose whole genome sequencing, including both short-read and long-read, exome, epigenome, and transcriptome sequencing, as well as proteomic, metabolomic, and single-cell RNA sequencing and ATAC sequencing, when justified. The omics data and related phenotypic data will be deposited in a public INCLUDE Project controlled-access database.

Eligible Applicant Types

Not yet categorized.

Geographic Eligibility
Nationwide
Related News 5 articles
New $3.8M NIH grant funds research on 'mind after midnight' as a suicide risk factor - University of Arizona News
University of Arizona News · May 21, 2026
Recent National Institutes of Health Grant Terminations Disproportionately Impacted BIPOC Scientists - The Journal of Blacks in Higher Education
The Journal of Blacks in Higher Education · May 11, 2026
EU universities urged to consider: ‘Is NIH funding worth it?’ - Research Professional News
Research Professional News · May 8, 2026
‘Highly problematic for a thousand reasons’: NIH employees criticize Trump-era requirement to scrutinize grants with words related to diversity - Government Executive
Government Executive · May 7, 2026
Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings - National Institutes of Health (.gov)
National Institutes of Health (.gov) · May 6, 2026
Powered by Google News
🔒

Create a Free Account

Sign up to save grants, set alerts, and get personalized matches for your county — completely free.

Create Free Account I Already Have an Account